
    
      Compare the two arms of the study in terms of:

      A. each element contributing to the primary criterium;

      B. the quality of chemotherapy related care;

      C. logistics;

      D. patient satisfaction with respect to support for chemotherapy care;

      E. the feasibility and acceptability of the organization by patients will be assessed by the
      rate of optimal use of toxicity collection tools and patient satisfaction rates relative to
      the tool (experimental arm)

      F. Comparison of the overall cost of care in both arms and estimated cost of the strategy
    
  